Loading...
OTCM
BLMS
Market cap6kUSD
Jul 21, Last price  
0.00USD
1D
0.00%
1Q
0.00%
IPO
-99.92%
Name

Bloomios Inc

Chart & Performance

D1W1MN
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
91.84%
Rev. gr., 5y
%
Revenues
6m
-28.43%
000000001,316,3048,491,6516,077,080
Net income
-15m
L+566.45%
-47,709-63,2360-2,245,503681,258-108,165-10,000-16,863-1,241,640-2,266,308-15,103,787
CFO
-6m
L+6,320.80%
-60,404-50,189-16,441-562,540-89,640-23,439-10,000-16,863821,026-98,519-6,325,707

Profile

Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.
URL
https://www.bloomios.com/
IPO date
Oct 14, 2003
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2022‑122021‑122020‑122020‑012019‑01
Income
Revenues
6,077
-28.43%
Cost of revenue
9,717
Unusual Expense (Income)
NOPBT
(3,640)
NOPBT Margin
Operating Taxes
1,330
Tax Rate
NOPAT
(4,970)
Net income
(15,104)
566.45%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
22,326
Long-term debt
207
Deferred revenue
Other long-term liabilities
(150)
Net debt
22,541
Cash flow
Cash from operating activities
(6,326)
CAPEX
(24)
Cash from investing activities
(24)
Cash from financing activities
6,079
FCF
(3,508)
Balance
Cash
(57)
Long term investments
50
Excess cash
Stockholders' equity
(7,756)
Invested Capital
28,911
ROIC
ROCE
EV
Common stock shares outstanding
13,200
Price
0.95
-50.00%
Market cap
12,540
-47.73%
EV
43,581
EBITDA
(3,201)
EV/EBITDA
Interest
966
Interest/NOPBT